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ABSTRACT
The synthesis of a new molecule, acetylpyrazine ethylthiosemicarbazone (APZ-ETSC) is presented and 
its structural characterization is described with NMR techniques using experiments from a 500 MHz 
Bruker Nuclear Magnetic Resonance (NMR) Spectrometer. The 1H, 13C-Distortionless Enhancement by 
Polarization Transfer (DEPT), 1H-13C Heteronuclear Single Quantum Coherence (HSQC), 1H-13C 
Heteronuclear Multiple Bond Coherence (HMBC), 1H-15N HSQC, and 1H-15N HMBC experiments were 
conducted with the NMR spectrometer, and the chemical shifts obtained by these experiments were 
correlated to confirm the assignments of the spectral peaks of the new molecule. These NMR 
experiments give evidence for the hypothesized structure of APZ-ETSC in solution. 
 The target of these medications is usually DNA (6). Cisplatin binds 
covalently to two Guanine base pairs preventing RNA synthesis and 
DNA repair (6).  New metal complexes of α-(N)-heterocyclic 
thiosemicarbazones (10) have anti-cancer activity like Cisplatin, 
however, these molecules target enzymes instead of DNA itself. 
The goal of our research is to synthesize new α-(N)-heterocyclic 
thiosemicarbazones molecules like APZ-ETSC. Use of these new 
molecules as a medicine requires that we fully elucidate the 
structure of these molecules in the solution state, so that we can 
predict how they interact with enzymes to understand their mode of 
action.
Materials and Methods
Starting materials, chemicals [1] (2-acetylpyrazine) and [2] (4-
ethyl-3-thiosemicarbazide), were all purchased from Sigma-Aldrich 
and used without modification unless otherwise noted. NMR spec-
troscopy was carried out at the Center for Structural Chemistry, Ten-
nessee Technological University (USA).  The spectra reported here 
were measured with a Bruker Avance III HD 500 spectrometer at 
500.13 MHz (1H), 50.69 MHz (15N) and 125.03 MHz (13C) at 25 °C. 
For these measurements the substances were dissolved in deuter-
ated dimethyl sulfoxide and the chemical shifts were referenced to 
the residual solvent peak. Coupling constants (J) are given in Hertz 
(Hz). 1H NMR experiments were acquired using Bruker’s standard 
Proton (zg30) NMR pulse sequence with the following parameters: 
Relaxation delay, 1s; 90° pulse, 12.0 µs; spectral width, 10,000 Hz; 
number of data points, 32K; and digital resolution, 0.153 Hz/point. 
Synthesis of [3] APZ-ETSC, 
N-Ethyl-2-[1-(2-pyrazinyl)ethylidene]hydrazinecarbothioamide
In a 50mL Erlenmeyer flask equipped with a magnetic stir bar, was 
placed [1] 2-acetylpyrazine, (3.03x10-3 mol, 0.403g), and [2] 4-
ethyl-3-thiosemicarbazide, (3.03x10-3 mol, 0.393g) dissolved in 
20mL of isopropanol with one drop of concentrated sulfuric acid 
catalyst. The reaction mixture was heated to 60 0C overnight. After 
24 hours, the light-yellow product was filtered and dried to yield [3] 
APZ-ETSC , 2.18x10-3mol, 0.528g, (66% yield).
1H NMR (500 MHz, DMSO-d6) δ 10.41 (s, 1H), 9.64 (d, J = 1.4 
Hz, 1H), 8.82 (t, J = 6.0 Hz, 1H), 8.69 – 8.40 (m, 2H), 3.74 – 3.51 
(m, 2H), 2.35 (s, 3H), 1.16 (t, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, DMSO) δ 177.61, 150.10, 145.74, 143.79, 
143.15, 143.04, 38.61, 14.39, 11.78
Acronyms
APZ – 2-Acetyl pyrazine
ETSC – 2-Ethyl-4-thiosemicarbazide
NMR – Nuclear Magnetic Resonance
HSQC – Heteronuclear Single Quantum Coherence
HMBC – Heteronuclear Multiple Bond Coherence
APZ-ETSC – Acetylpyrazine Ethylthiosemicarbazone
Introduction
Thiosemicarbazones and their derivatives have been researched for 
many years, and have been shown to have a variety of pharmacol-
ogical applications (1,2,3). A subset of the thiosemicarbazones, named 
α-(N)-heterocyclic thiosemicarbazones, are of interest as chemother-
apy agents (1,2). Their specific α-(N)-heterocyclic backbone ring is 
designed to adopt a structure that allows them to bind to transition 
metals very efficiently, and they are tridentate ligands (1,2,4). This 
allows them to interact with enzymes that contain transition metals, 
such as ribonucleotide reductase, and render them inoperative. One 
of these α-(N)-heterocyclic thiosemicarbazones is triapine, and it is 
currently used as a chemotherapy agent. The 2-acetyl pyridine thio-
semicarbazones, which are similar to triapine, have been shown to 
inhibit a variety of microbial growths including Neisseria gonor-
rhoeae, Staphylococcus faecalis, Streptococcus faecalis, and D. En-
terococcus (1,2,3). 2-(α-hydroxyacetyl) pyridine thiosemicarbazone 
has been shown to inhibit both penicillin-sensitive and resistant 
strains of N. Gonorrheae, N. Menigitides, and Staphylococcus 
aureus (1,2,3). It is hypothesized that these compounds have a higher 
activity when complexed with transition metals due to an increase in 
the lipophilicity (1). Our research involves making analogues of 
triapine.
Literature shows that some 2-acetylpyrazine thiosemicarbazone 
(APZ-TSC) derivatives possess antifungal activity against several 
types of fungi including Candida albicans (4). A structurally similar 
compound, 2-acetylpyridine thiosemicarbazone has shown antimi-
crobial activity against several microorganisms (5). Past work in our 
laboratory focused on the synthesis and characterization of many 
thiosemicarbazones that share the common backbone with these 
previously reported compounds and their metal complexes (7,8,9).
There are currently pharmaceuticals employing metal-ligand com-
plexes on the market such as cis-diammedichloridoplatium (II), also 
called Cisplatin, which are used to treat some types of cancers. 
However, these drugs have severe side effects, and are fairly lim-
ited in the type of tumors that can be treated with Cisplatin (6).  
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Results and Discussion 
The acid catalyzed condensation of 2-acetylpyrazine and a thiosemi-
carbazide reagent in isopropyl alcohol to produce compound [3] is 
shown in Figure 1. The product [3] precipitated from isopropyl 
alco-hol and was separated by filtration with no further purification 
needed. This synthesis procedure can theoretically be applied to 
utilize any side chain on the thiosemicarbazide such as a benzyl, 
phenyl, tertbutyl, or dimethyl. Filtration at room temperature 
yielded 66% collection of [3], cold filtration was found to increase 
the yield; however, the product is not as pure as in the first crop.
Figure 1. Synthesis drawing of the Title Compound [3] APZ-ETSC.
To characterize [3], several spectra were acquired and used to as-
sign the hydrogen, carbon, and nitrogen signals. Each carbon and 
nitrogen were numbered, 1-15, with the protons sharing a number 
with the atom to which it is directly bonded as seen in Figure 2. 
Figure 2. The 1H-NMR Spectrum of APZ-ETSC in DMSO-d6.
The two one-dimensional spectra obtained were the 1H-NMR (Fig-
ure 2) and the 13C-NMR DEPTQ-135 (Figure 4) and used to pro-
pose initial assignments. From the 1H-NMR, the number of protons 
are determined from the integration of the area under the peaks. The 
splitting and coupling patterns show the number of adjacent pro-
tons. In Figure 2, the most up-field signal is at 1.16 ppm and it inte-
grates for 3 protons, and its triplet splitting pattern indicates there 
are 2 more protons 3 bonds from those in the signal. This is most 
likely the methyl group protons numbered 15 in Figure 2. The com-
plex multiplet signal at 3.74 – 3.51 ppm integrates for 2 protons, 
and the complex splitting pattern indicates there is more than one 
coupling happening at different intensities. This would be expected 
of the protons numbered 14 with one of the coupling protons being 
attached to a nitrogen instead of a carbon atom. The singlet peak at 
2.35 indicates an isolated methyl group that is not coupling with 
any neighboring protons; this must be the group numbered 12. The 
four peaks above 7 are all either bonded directly to a nitrogen or on 
the aromatic ring. The triplet at 8.82 has to be the proton on the ni-
trogen numbered 13 with the CH2 (14). The singlet at 10.42 is likely 
the other nitrogen attached proton because of its lack of cou-pling. 
The other two are more ambiguous because the aromatic ring’s 
Protons are in very similar environments. These may be determined 
using 2-dimensional spectroscopy.
The 13C-NMR DEPTQ-135 provides very important information in 
the positive and negative phase distinctions and number of signals 
it contains. The DEPTQ-135 is a modified DEPT experiment that 
shows each carbon environment present in the molecule including 
quaternary carbons as an individual signal and the phase of these 
signals indicates the number of hydrogens attached. The positive 
peaks are carbon atoms in either CH or CH3 groups; the negatives 
are carbon atoms in either CH2 or fully substituted Carbons. Using 
this the most down-field signal at 177.61 ppm is most likely the Car-
bon numbered 10. The other two quaternary Carbons, 2 and 7 are 
harder to distinguish; the signal at 150.10 ppm is more likely to be 
7 because of the electron withdrawing effects of the aromatic ring 
and Nitrogen groups. The signal at 145.74 ppm is more likely to be 
2 because it is in the electronic environment of the aromatic ring 
where the delocalization of the electrons across the entire ring sys-
tem shields the atoms within that system significantly putting the 
signals more up-field than would be usually expected. 
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Figure 3. The 13C-NMR DEPTQ-135 of APZ-ETSC in DMSO-d6.
To confirm and elaborate on the assignments made above, two di-
mensional spectra were used. The first type being Heteronuclear 
Single Quantum Coherence Spectroscopy (HSQC). HSQC showed 
two atoms directly bonded to each other, in this case 1H-13C or 
1H-15N.  This spectra is created by matching the 1H-NMR with the 
corresponding 13C-NMR DEPT and 15N-NMR spectra. These two 
dimensional spectra are plotted to appear like topographical maps 
with concentric rings indicating signals.  The X-axis of HSQC spec-
tra are set in line with the 1H-NMR spectra discussed above and the 
Y-axis was aligned with either 13C or 15N one dimensional spectra as 
appropriate. Signals that appear in these 2D spectra show that the 1H 
and either 13C or 15N signals are connected by a single bond.
Figure 4. The 1H-13C HSQC NMR of APZ-ETSC in DMSO-d6.
As can be determined by Figure 4, the Carbon 15 has the signal at 
14.39 ppm, Carbon 14 has the signal at 38.61 ppm, and Carbon 12 
has the signal at 11.78 ppm. Each of these signals appear as a series 
of concentric rings between the attached carbon and proton NMR.
Figure 5. 1H-13C HMBC of APZ-ETSC in DMSO-d6.
HMBC spectra showed atoms that are 2-3 bonds away and come in 
the same varieties of 1H-13C and 1H-15N as HSQC.  These spectra 
show signals as concentric rings between 1D spectra as in HSQC, 
but indicate a greater number of bonds separating them, typically 2 
to 3 bonds.  The 1H-13C HMBC shown in Figure 5 helped to deter-
mine exactly which signals were which for the aromatic Carbons 3, 
5, and 6. It also helps to confirm Carbons 7 and 10 assignments 
where signals appear underneath hydrogen signals at 2.35 in line 
with a carbon at 145.74 indicating that they are 2 to 3 bonds apart 
in the case of carbon 7 and a signal is observed at 177.61 beneath a 
proton signal of 3.63 indicating a proximity of thiocarbonyl carbon 
10 is 2 to 3 bonds from the proton on position 14. In each case a 
signal was observed under the corresponding proton signal that was 
in line with the carbon signal on the Y-axis indicating the atoms 
were 2 to 3 bonds apart. The exact numbers of these assignments 
are in Table 1.
Figure 6. 1H-15N HSQC of APZ-ETSC in DMSO-d6.
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Using the 1H-15N HSQC in Figure 6, the assignments of the nitro-
gen atoms directly bonded to protons can be determined. Nitrogen 9 
is more downfield due to the withdrawing effects of the adjacent 
nitrogen and thiocarbonyl, and nitrogen 13 is slightly more up-field 
with the withdrawing effects of the thiocarbonyl slightly mitigated 
by the alkyl group. These 15N assignments are confirmed by 1H-15N 
HMBC in Figure 7, and nitrogen atoms 1, 4, and 8 are as-signed as 
well. Each of the nitrogen atoms not attached to a proton does not 
appear in the HSQC experiment. With the low natural abundance 
and sensitivity of 15N it is often difficult to observe 15N chemical 
shifts making this HMBC spectra a very useful method of 
observing nitrogen atoms 1, 4 and 8. 
This characterization with the assignment of all peaks in the spectra 
is the first step in determining the identity and purity of this poten-
tial medication. This process also confirms there is no other struc-
tural equilibrium or that the structures interchange faster than the 
observation time of the NMR experiment. These experiments can 
be compared to future works to see how the ligand changes when 
complexed with the metals. 
Figure 7. 1H-15N HMBC of APZ-ETSC in DMSO-d6.
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Future Works
This ligand will be complexed with transition metals such as plati-
num, palladium, and copper. Such metal compounds usually adopt 
a square planar geometry, and are hypothesized to inhibit human 
topoisomerase. These will be tested in vitro using enzyme assays 
and in vivo using breast cancer cells. 
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